Access Hybritech p2PSA Reagents on the Access Immunoassay Systems

FDA Premarket Approval P090026 S028

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Modification to the access 2 immunoassay system pipettor gantry

DeviceAccess Hybritech p2PSA Reagents on the Access Immunoassay Systems
Generic NameP2psa
ApplicantBECKMAN COULTER, INC.
Date Received2020-06-23
Decision Date2020-10-07
PMAP090026
SupplementS028
Product CodeOYA 
Advisory CommitteeImmunology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address BECKMAN COULTER, INC. 1000 Lake Hazeltine Dr. chaska, MN 55318

Supplemental Filings

Supplement NumberDateSupplement Type
P090026Original Filing
S031 2021-04-19 Real-time Process
S030 2020-09-30 Real-time Process
S029 2020-07-22 Real-time Process
S028 2020-06-23 Real-time Process
S027 2019-12-18 Real-time Process
S026 2019-05-13 Real-time Process
S025 2019-05-02 Real-time Process
S024
S023 2018-12-17 30-day Notice
S022 2018-09-25 Real-time Process
S021 2017-09-28 30-day Notice
S020
S019 2017-06-09 30-day Notice
S018 2017-03-22 Real-time Process
S017 2017-01-23 30-day Notice
S016 2017-01-17 30-day Notice
S015 2015-05-07 Real-time Process
S014 2014-11-04 135 Review Track For 30-day Notice
S013 2014-08-25 Real-time Process
S012 2014-08-25 135 Review Track For 30-day Notice
S011 2014-06-12 30-day Notice
S010 2013-12-17 Real-time Process
S009 2013-09-26 Special (immediate Track)
S008 2013-06-13 Special (immediate Track)
S007 2013-04-12 Special (immediate Track)
S006 2013-03-29 Real-time Process
S005 2013-01-23 Real-time Process
S004 2013-01-03 30-day Notice
S003
S002
S001 2012-10-25 Special (immediate Track)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.